ClinicalTrials.gg
Drug

Erenumab clinical trials

Also written Aimovig and AMG 334.

studies test it
52
open now
5
in phase 3
10
first study started
2012

How each study uses erenumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the erenumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
17 May 2018 · AIMOVIG · BLA 761077 (FDA, Drugs@FDA)
European Union
26 Jul 2018 · Aimovig · EMEA/H/C/004447 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Erenumab
40
Erenumab Dose 1
2
Erenumab Dose 2
2
Erenumab Dose 3
2
Erenumab 70 mg
2

Brand

Aimovig
31

Development codes

AMG 334
24

Studies by the year they started

52 studies that test it; most in 2019 (15)

Studies that test erenumab, by start year
YearStudies
20122
20132
20142
20154
20163
20171
20182
201915
20209
20216
20224
20231
20261

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
16
Phase 3
10
Phase 4
16
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 32 · Other 20

Amgen (23) · Novartis Pharmaceuticals (7) · Danish Headache Center (6) · Mayo Clinic (4) · University of Maryland, Baltimore (2) · Indiana University (1) · Charite University, Berlin, Germany (1) · Merle Diamond (1)

Often tested with

Tested in the same studies.

Galcanezumab (3) · Eptinezumab (2) · Ubrogepant (1) · Atogepant (1) · Siltuximab (1) · Calcitonin Gene-Related Peptide (1) · Onabotulinum toxin A (1) · Botulinum toxin type A (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test erenumab.

Studies

Open first, then newest update. How each study uses erenumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 52

See all 52 studies that test erenumab →

As the comparator · 1 — what is tested is compared with erenumab

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call erenumab · ClinicalTrials.gg INT000414

  • MeSH (NLM) C000605816erenumabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) I5I8VB78VTERENUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 2045613Confirmed FDA, Wikidata
  • Wikidata Q28209017erenumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C169958ErenumabOne source FDA
  • DrugBank DB14039One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.